Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy

NCT02351531 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-01-30

No results posted yet for this study

Summary

The aim of the study is to assess the hypoallergenicity of a new thickened extensively hydrolyzed formula.

Conditions

  • Cow Milk Allergy

Interventions

DIETARY_SUPPLEMENT

Extensively Hydrolyzed formula

Sponsors & Collaborators

  • United Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-12-31

Countries

  • Belgium
  • France
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351531 on ClinicalTrials.gov